Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Optimal management of Meniere's disease
Which is right for you is determined at your clinical evaluation
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
What effects might exenatide have on non-motor symptoms in Parkinsons disease: a post hoc analysis
UAN: 430-0000-18-049-H01-P Credits: 2.0 hours (0.20 ceu) Type of Activity: Knowledge TARGET AUDIENCE: This accredited activity is targeted to pharmacists
All authors were involved in the drafting, critical review, revision, and final approval of the manuscript
US$ 26.31
US$ 25.99
US$ 23.79
